MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fnut.2026.1818356

Медицинская библиотека · Frontiers in nutrition · 2026

Serum uric acid-to-albumin ratio as a novel predictor of all-cause mortality and cardiovascular events in hemodialysis patients: a retrospective cohort study.

Zhou Qin, Guan Qian, Xu Li, Bai Haitao, Chen Wenli, Xingruo Zeng, Liu Changxuan

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Cardiovascular disease (CVD) is the leading cause of death in patients undergoing hemodialysis. The uric acid-to-albumin ratio (UAR), a novel marker, has been linked to cardiovascular diseases. However, its role in patients undergoing hemodialysis has not yet been studied. We aimed to investigate the association between UAR and the all-cause mortality and CVD events in hemodialysis patients.

METHODS

This single center retrospective cohort study was conducted between January 2021 and April 2024. Based on baseline UAR values, patients were categorized into tertiles. The associations between UAR and clinical outcomes were examined using Univariate and multivariate Cox regression models. Kaplan-Meier curves were used to estimate cumulative survival and CVD-free survival rates.

RESULTS

A total of 310 patients undergoing hemodialysis were included. During the 40-month follow-up period, 101 (32.6%) died, and 105 (33.9%) experienced new-onset CVD events. Kaplan-Meier survival curves showed significantly higher mortality rates in the middle and high UAR groups than in the low UAR group (Log rank= 10.684, P= 0.005). Patients in high UAR group were more likely to experience CVD events (Log rank= 14.006, P= 0.001). Multivariate Cox regression analysis revealed that, even after adjustment for traditional risk factors, high UAR remained significantly associated with an increased risk of all-cause mortality and new-onset CVD events (HR: 2.431, 95% CI: 1.407-4.200, P = 0.001; HR: 2.163, 95% CI: 1.304-3.588, P = 0.003; respectively).

CONCLUSION

This study demonstrates for the first time that UAR is independently and significantly associated with all-cause mortality and CVD events in patients undergoing hemodialysis. These findings position UAR as a composite biomarker integrating inflammatory, metabolic, and nutritional pathways and provide a novel perspective for improving outcomes in patients undergoing hemodialysis.

Для цитирования: Zhou Qin, Guan Qian, Xu Li, Bai Haitao, Chen Wenli, Xingruo Zeng, Liu Changxuan. Serum uric acid-to-albumin ratio as a novel predictor of all-cause mortality and cardiovascular events in hemodialysis patients: a retrospective cohort study.. Frontiers in nutrition. 2026. DOI: 10.3389/fnut.2026.1818356.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.